228 related articles for article (PubMed ID: 11125290)
21. Pretargeting strategies for radio-immunoguided tumour localisation and therapy.
Stoldt HS; Aftab F; Chinol M; Paganelli G; Luca F; Testori A; Geraghty JG
Eur J Cancer; 1997 Feb; 33(2):186-92. PubMed ID: 9135486
[TBL] [Abstract][Full Text] [Related]
22. Exploration of novel strategies to enhance monoclonal antibodies targeting.
Khawli LA; Epstein AL
Q J Nucl Med; 1997 Mar; 41(1):25-35. PubMed ID: 9195850
[TBL] [Abstract][Full Text] [Related]
23. Tailoring antibodies for radionuclide delivery.
Kenanova V; Wu AM
Expert Opin Drug Deliv; 2006 Jan; 3(1):53-70. PubMed ID: 16370940
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunodiagnosis and therapy.
Verhaar-Langereis MJ; Zonnenberg BA; de Klerk JM; Blijham GH
Cancer Treat Rev; 2000 Feb; 26(1):3-10. PubMed ID: 10660488
[TBL] [Abstract][Full Text] [Related]
25. Is there a future role for immunoscintigraphy in the diagnosis of colorectal carcinoma?
Artiko VM; Sobić-Saranović DP; Krivokapić ZV; Petrović MN; Obradović VB
Neoplasma; 2009; 56(1):1-8. PubMed ID: 19152238
[TBL] [Abstract][Full Text] [Related]
26. Principles of radioimmunotherapy for hematologists and oncologists.
Press OW; Rasey J
Semin Oncol; 2000 Dec; 27(6 Suppl 12):62-73. PubMed ID: 11226002
[TBL] [Abstract][Full Text] [Related]
27. Radioimmunodetection of solid tumors. Future horizons and applications for radioimmunotherapy.
McKearn TJ
Cancer; 1993 Jun; 71(12 Suppl):4302-13. PubMed ID: 8508392
[TBL] [Abstract][Full Text] [Related]
28. The current status of radiolabeled monoclonal antibodies for the diagnosis and treatment of human malignancies.
Kuzel TM; Duda RB
Compr Ther; 1992 Jun; 18(6):16-20. PubMed ID: 1511591
[No Abstract] [Full Text] [Related]
29. A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled rituximab in patients with refractory B-cell lymphoma.
Lindén O; Kurkus J; Garkavij M; Cavallin-Ståhl E; Ljungberg M; Nilsson R; Ohlsson T; Sandberg B; Strand SE; Tennvall J
Cancer Biother Radiopharm; 2005 Aug; 20(4):457-66. PubMed ID: 16114994
[TBL] [Abstract][Full Text] [Related]
30. Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan and prospects for therapy.
Goldenberg DM; Juweid M; Dunn RM; Sharkey RM
J Nucl Med Technol; 1997 Mar; 25(1):18-23; quiz 34. PubMed ID: 9239599
[TBL] [Abstract][Full Text] [Related]
31. Current status and perspectives in alpha radioimmunotherapy.
Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
[TBL] [Abstract][Full Text] [Related]
32. Advances in cancer therapy with radiolabeled monoclonal antibodies.
Goldenberg DM; Sharkey RM
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):248-64. PubMed ID: 17043623
[TBL] [Abstract][Full Text] [Related]
33. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
34. Copper-67 as a therapeutic nuclide for radioimmunotherapy.
Novak-Hofer I; Schubiger PA
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):821-30. PubMed ID: 12029558
[TBL] [Abstract][Full Text] [Related]
35. Genetically engineered monoclonal antibodies armed with radionuclides.
Waldmann TA
Year Immunol; 1993; 7():205-12. PubMed ID: 8103951
[No Abstract] [Full Text] [Related]
36. Optimization of 90 Y-antiCD20 preparation for radioimmunotherapy.
Gholipour N; Vakili A; Radfar E; Jalilian AR; Bahrami-Samani A; Shirvani-Arani S; Ghannadi-Maragheh M
J Cancer Res Ther; 2013; 9(2):199-204. PubMed ID: 23771358
[TBL] [Abstract][Full Text] [Related]
37. New insights into the pretargeting approach to image and treat tumours.
Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
[TBL] [Abstract][Full Text] [Related]
38. The role of radioisotopes in radiation oncology.
Park CH
Semin Oncol; 1997 Dec; 24(6):639-54. PubMed ID: 9422261
[TBL] [Abstract][Full Text] [Related]
39. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
